Russian Republic to Produce Apitherapy Products

Kulinski District of Dagestan Implements a Number of Large Investment Projects

Makhachkala, April 5, 2011 - The Kulinski district administration along with the Republican Agency for Investment and Foreign Economic Relations developed an investment passport of the region.

According to the passport data the local administration intends to create a big animal farm in the settlement of Tsovkra.

10:00 PM | 0 komentar | Read More

Bee Venom Has Anti-Inflammatory Effect

Malaysian Bee Venom Abrogates Carrageenan Induced Inflammation in Rats
Journal of ApiProduct & ApiMedical Science, Vol. 3 (2) pp. 75 - 80

This study was carried out to test the hypothesis that Malaysian bee venom (MBV) has the potential to produce a potent anti-inflammatory effect.

MBV was obtained by electrical stimulation technique without causing death to the bees. An animal model with

10:00 PM | 0 komentar | Read More

Article Outlines Health Benefits of Bee Products

Jury’s Out on Honey’s Health Benefits, But Buzz Grows By Kim Mulford, (Cherry Hill, N.J.) Courier-Post, 3/28/2011

CHERRY HILL, N.J. — Ancient Greeks and Egyptians used it. So did your grandmother. But modern medicine hasn’t fully recognized the health benefits of honey and other bee products.

Few well-controlled studies have been done on the effectiveness of apitherapy, or the medical use of

10:00 PM | 0 komentar | Read More

New Apitherapy Quality Standards Project

By Horacio Mezziga, ApiNews, 3/21/2011

The Apitherapy Commission of Apimondia has set up new program to establish a standard of quality for products pertaining to Apitherapy. The program will provide a Gold Label which will protect the name apitherapy from being used for products that fail to reach the standards demanded in medicine.

Many years of research in the apitherapy field have given

10:00 PM | 0 komentar | Read More

Clinical Trials to Start for Bee Venom Arthritis Product

American Bee Journal, March 2011

Apimeds, Inc. US Chief Operating Officer Robert Brooks PhD announced the company received a clearance letter from the US Food & Drug Administration on December 22nd authorizing the company to proceed with its Phase III clinical trial. Apimeds plans the launch of its Phase III Apitox, a honeybee toxin, for the indication of pain and inflammation of osteoarthritis

10:00 PM | 0 komentar | Read More